{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:01:22Z","timestamp":1768525282677,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cllc.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:41:33Z","timestamp":1658371293000},"page":"561-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Updated Review on Radiation Treatment Management in Thymus Cancers"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2287-2320","authenticated-orcid":false,"given":"Jason","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameish","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta","family":"Erhunmwunsee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Raz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminia","family":"Massarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Salgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6205-5969","authenticated-orcid":false,"given":"Arya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2022.07.004_bib0001","article-title":"Cancer statistics, 2020","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2022.07.004_bib0002","first-page":"1383","article-title":"The 2015 World Health Organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0003","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0004","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.cllc.2022.07.004_bib0006","first-page":"1","article-title":"Thymomas and thymic carcinomas","author":"Ettinger","year":"2021","journal-title":"NCCN Guidel"},{"issue":"Suppl 5","key":"10.1016\/j.cllc.2022.07.004_bib0007","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","article-title":"Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Girard","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.cllc.2022.07.004_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5306\/wjco.v12.i4.195","article-title":"GOECP\/SEOR radiotherapy guidelines for thymic epithelial tumours","volume":"12","author":"Rico","year":"2021","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.cllc.2022.07.004_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ctrv.2018.10.001","article-title":"Best practices for the management of thymic epithelial tumors: a position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)","volume":"71","author":"Imbimbo","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cllc.2022.07.004_bib0010","first-page":"911","article-title":"The management of thymoma: a systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0011","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cncr.10373","article-title":"Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0012","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0013","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.21037\/jtd-2019-thym-09","article-title":"The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature","volume":"12","author":"Bruni","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cllc.2022.07.004_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40880-017-0213-8","article-title":"Long-term outcomes of 307 patients after complete thymoma resection","volume":"36","author":"Yuan","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0015","first-page":"136","article-title":"Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases","volume":"112","author":"Zhang","year":"1999","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cllc.2022.07.004_bib0016","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2016.01.007","article-title":"Survival impact of adjuvant radiation therapy in Masaoka Stage II to IV thymomas: a systematic review and meta-analysis","volume":"94","author":"Lim","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2022.07.004_bib0017","first-page":"677","article-title":"Postoperative radiotherapy for completely resected Masaoka\/Masaoka-Koga Stage II\/III thymoma improves overall survival: an updated meta-analysis of 4746 patients","volume":"16","author":"Tateishi","year":"2021","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0018","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2016.12.042","article-title":"A meta-analysis of postoperative radiotherapy for thymic carcinoma","volume":"103","author":"Hamaji","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0019","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","article-title":"Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection","volume":"6","author":"Curran","year":"1988","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.cllc.2022.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the international thymic malignancies interest group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2022.07.004_bib0021","first-page":"734","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0003-4975(02)03828-6","article-title":"Adjuvant radiation therapy for stage II thymoma","volume":"74","author":"Mangi","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0023","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ijrobp.2009.09.066","article-title":"Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection","volume":"78","author":"Chen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2022.07.004_bib0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ejcts\/ezz001","article-title":"Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma","volume":"56","author":"Okumura","year":"2019","journal-title":"Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0025","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.18632\/oncotarget.24315","article-title":"Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study","volume":"9","author":"Bian","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cllc.2022.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/ejcts\/ezw178","article-title":"Prognostic impact of tumour size in completely resected thymic epithelial tumours","volume":"50","author":"Fukui","year":"2016","journal-title":"Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg"},{"issue":"Suppl 15","key":"10.1016\/j.cllc.2022.07.004_bib0027","doi-asserted-by":"crossref","first-page":"S2005","DOI":"10.21037\/jtd.2019.06.40","article-title":"Thymoma: does tumor size matter?","volume":"11","author":"Amini","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cllc.2022.07.004_bib0028","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cncr.29166","article-title":"Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese association for research on the thymus database study","volume":"121","author":"Omasa","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0029","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2009.02.016","article-title":"Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease","volume":"76","author":"Forquer","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7 Suppl 3","key":"10.1016\/j.cllc.2022.07.004_bib0030","first-page":"S1743","article-title":"Radiation therapy definitions and reporting guidelines for thymic malignancies","volume":"6","author":"Gomez","year":"2011","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0031","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1010-7940(01)00666-2","article-title":"The multimodality treatment of thymic carcinoma","volume":"19","author":"Lucchi","year":"2001","journal-title":"Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0032","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0033","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2022.07.004_bib0035","first-page":"2023","article-title":"A pilot study of cisplatin and etoposide with and without radiotherapy for advanced malignant thymoma","volume":"34","author":"Tamiya","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2022.07.004_bib0036","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0037","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2022.07.004_bib0038","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2022.07.004_bib0039","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2019.12.045","article-title":"Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: a prospective phase 2 study","volume":"107","author":"Fan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2022.07.004_bib0040","unstructured":"Wu K-L. Adjuvant Radiotherapy for Stage II\/III Thymoma After Complete Resection. Clinicaltrials.gov.:NCT02633553."},{"key":"10.1016\/j.cllc.2022.07.004_bib0041","unstructured":"Zhang Y. Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma. Clinicaltrials.gov.:NCT02014805."},{"key":"10.1016\/j.cllc.2022.07.004_bib0042","unstructured":"Nyasse F. Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II\/III Thymoma (RADIO-RYTHMIC). Clinicaltrials.gov.:NCT04731610."},{"key":"10.1016\/j.cllc.2022.07.004_bib0043","unstructured":"Nyman J. Study on Proton Radiotherapy of Thymic Malignancies (PROTHYM). Clinicaltrials.gov.:NCT04822077."},{"key":"10.1016\/j.cllc.2022.07.004_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12909-z","article-title":"Prospective study of stereotactic body radiation therapy for thymoma and thymic carcinoma: therapeutic effect and toxicity assessment","volume":"7","author":"Hao","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.cllc.2022.07.004_bib0045","first-page":"e1056","article-title":"Thymic carcinoma treated by CyberKnife stereotactic body radiotherapy","volume":"9","author":"Harada","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.cllc.2022.07.004_bib0046","unstructured":"Zhou Y. Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma. Clinicaltrials.gov.:NCT04554524."},{"key":"10.1016\/j.cllc.2022.07.004_bib0047","unstructured":"Garassino MC. Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma \/B3 Thymoma With Carcinoma (RELEVENT). Clinicaltrials.gov.:NCT03921671."},{"key":"10.1016\/j.cllc.2022.07.004_bib0048","unstructured":"Girard N. Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM). Clinicaltrials.gov.:NCT03134118."},{"key":"10.1016\/j.cllc.2022.07.004_bib0049","unstructured":"Wu K-L. A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma. Clinicaltrials.gov.:NCT04321330."},{"key":"10.1016\/j.cllc.2022.07.004_bib0050","unstructured":"Owen D. Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer. Clinicaltrials.gov.:NCT03463460."},{"key":"10.1016\/j.cllc.2022.07.004_bib0051","unstructured":"Remon J. Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (PECATI). Clinicaltrials.gov.:NCT04710628."},{"key":"10.1016\/j.cllc.2022.07.004_bib0052","unstructured":"Giaccone G. Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma. Clinicaltrials.gov.:NCT02364076."},{"key":"10.1016\/j.cllc.2022.07.004_bib0053","unstructured":"Rajan A. Sunitinib for Advanced Thymus Cancer Following Earlier Treatment. Clinicaltrials.gov.:NCT01621568."},{"key":"10.1016\/j.cllc.2022.07.004_bib0054","unstructured":"Loehrer P. A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer. Clinicaltrials.gov.:NCT00369889."}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:13:03Z","timestamp":1761505983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730422001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1525730422001565"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2022.07.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Updated Review on Radiation Treatment Management in Thymus Cancers","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}